Skip to main content

India to launch Europe’s Proba-3 set to create artificial eclipse

The European Space Agency's Proba-3 mission is set to launch on India's PSLV in September. The innovative mission involves two small satellites, a Coronagraph and an Occulter, flying in tight formation about 150 meters apart. The Occulter will cast its shadow onto the Coronagraph, creating an artificial eclipse, allowing the observation of the Sun's faint corona in visible, ultraviolet, and polarized light for extended periods. The mission aims to provide new insights into coronal mass ejections and measure solar irradiance, potentially influencing our understanding of Earth's climate.

from Times of India https://ift.tt/3hANJB9
via

Comments

Popular posts from this blog

Kashmiri Pandit killed in J&K's Shopian, 7th since 2020

A terrorist shot dead 43-year-old Kashmiri Pandit farmer Puran Krishan Bhat outside his home in Choudharygund village of south Kashmir’s Shopian district Saturday morning, triggering protests in Jammu against the latest targeted attack on the community. DIG Sujit Kumar said Kashmir Freedom Fighter (KFF), the proxy name of a terrorist outfit, claimed responsibility for the attack on Bhat. from Times of India https://ift.tt/Sk9sv5q via

Wet spell likely in north & central India till Jan 9: IMD

The India Meteorological Department (IMD) on Wednesday predicted a wet spell over northwest India, including Delhi-NCR, Punjab and Haryana, and central India till January 9 due to two consecutive active western disturbances. It, however, said that there may not be cold wave conditions over north India during the next five days. from Times of India https://ift.tt/34pJ29g via

Molnupiravir has serious safety concerns: ICMR chief

Antiviral drug molnupiravir, which recently got approval from the drug regulator and is being launched by several local drug makers, has serious safety concerns, and thus has not been included in the national Covid-19 clinical protocol recommended by the health ministry, the Indian Council of Medical Research (ICMR) director general Balram Bhargava said. from Times of India https://ift.tt/3pXmODT via